The Vascular System in the Endometrium: Introduction and Overview

In: Vascular Morphogenesis in the Female Reproductive System · 2001 · pp. 209–222 · doi:10.1007/978-1-4612-0213-4_11 · W17603754
book-chapter OA: closed CC0 ⤵ 2 in-corpus citations
Full text JSON View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This section provides an overview of endometrial vascular structure and function during normal and pathological gynecologic conditions, detailing hormonal regulation and potential therapeutic targets.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text

This paper provides an overview of how the endometrium’s vascular system is structured and regulated, covering physiologic angiogenesis and regression across growth, implantation, and menstruation, and discussing pathologic contexts such as endometriosis, menorrhagia, breakthrough bleeding, adenomyosis, and fibroids. It highlights the regulatory roles of estrogen and progesterone in endometrial vasculature and summarizes local factors involved in controlling blood vessel growth, stability, and function. It points to a rapidly increasing understanding of vessel regulation that could enable new therapies, including angiogenesis inhibitors and approaches targeting vessel stabilization to address bleeding and vessel fragility. The paper itself is an introduction/overview section rather than an original study, and it does not present new experimental results or specific limitations beyond its narrative scope. This paper is centrally about endometriosis — it specifically includes endometriosis as a pathologic context for endometrial vascular regulation and outlines angiogenesis-inhibitor strategies as a potential treatment direction.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The chapters in this section describe endometrial vascular structure and function, with particular emphasis on normal physiologic events such as growth, implantation, and menstruation, as well as pathologic situations such as endometriosis, menorrhagia, breakthrough bleeding, adenomyosis, and fibroids. The role that estrogen and progesterone play in regulating the endometrial vasculature during these processes is discussed, as are various other factors that regulate vascular function at a local level. The recent sudden increase in understanding of how blood vessel growth and regression is regulated, coupled with the major involvement of uterine vasculature in almost all clinically relevant gynecologic disorders, has opened exciting new possibilities for medical treatment. The challenge for scientists and clinicians working in this field will be to harness the promise that this knowledge brings to develop effective new therapies. Possible novel treatments that could be considered include use of angiogenesis inhibitors to prevent endometriosis, and vessel stabilization and maturation factors to reduce vessel fragility and breakthrough bleeding. The latest information in this rapidly developing field is detailed in the chapters in this section, with contributions from three of the leading groups currently working on different aspects of the regulation of endometrial vascular structure and function.
Full text 17,094 characters · extracted from oa-doi-fallback · 3 sections · click to expand

Abstract

The chapters in this section describe endometrial vascular structure and function, with particular emphasis on normal physiologic events such as growth, implantation, and menstruation, as well as pathologic situations such as endometriosis, menorrhagia, breakthrough bleeding, adenomyosis, and fibroids. The role that estrogen and progesterone play in regulating the endometrial vasculature during these processes is discussed, as are various other factors that regulate vascular function at a local level. The recent sudden increase in understanding of how blood vessel growth and regression is regulated, coupled with the major involvement of uterine vasculature in almost all clinically relevant gynecologic disorders, has opened exciting new possibilities for medical treatment. The challenge for scientists and clinicians working in this field will be to harness the promise that this knowledge brings to develop effective new therapies. Possible novel treatments that could be considered include use of angiogenesis inhibitors to prevent endometriosis, and vessel stabilization and maturation factors to reduce vessel fragility and breakthrough bleeding. The latest information in this rapidly developing field is detailed in the chapters in this section, with contributions from three of the leading groups currently working on different aspects of the regulation of endometrial vascular structure and function. Preview Unable to display preview. Download preview PDF. Similar content being viewed by others

References

Abberton, K. M., Taylor, N. H., Healy, D. L., and Rogers, P. A. W. 1999. Vascular smooth muscle cell proliferation in arterioles of the human endometrium. Hum. Reprod. 14:1072–1079. Asahara, T., Masuda, H., Takahashi, T., Kalka, C., Pastore, C., Silver, M., Kearne, M., Magner, M., and Isner, J. M. 1999. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ. Res. 85:221–228. Au, C. L., and Rogers, P. A. W. 1993. Immunohistochemical staining of von Willebrand factor in human endometrium during normal menstrual cycle. Hum. Reprod. 8:17–23. Auerbach, R., Alby, L., and Morrissey, L. W, Tu, M., Joseph, J. 1985. Expression of organ-specific antigens on capillary endothelial cells. Microvasc. Res. 29:401–411. Ausprunk, D. H., Knighton, D. R., and Folkman, J. 1974. Differentiation of vascular endothelium in the chick chorioallantois: a structural and autoradiographic study. Dev. Biol. 38:237–248. Bartelmez, G. W. 1933. Histologic studies on the menstruating mucous membrane during menstruation. Contrib. Embryo. 142:142–157. Burri, P. H., and Tadek, M. R. 1990. A novel mechanism of capillary growth in the rat pulmonary microcirculation. Anat. Rec. 228:35–45. Charnock-Jones, D. S., Sharkey, A. M., Rajput-Williams, J., Burch, D., Schofield, J. P., and Fountain, S. A. 1993. Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod. 48:1120–1128. Clapp, C., Martial, J. A., Guzman, R. C., Rentier-Delure, F., and Weiner, R. I. 1993. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292–1299. Clark, K. E. 1997. Modulation of vascular responsiveness by steroids. Curr. Opin. Endocrinol. Diabetes 4:392–400. Coulam, C. B., Bustillo, M., Soenksen, D. M., and Britten, S. 1994. Ultrasonographic predictors of implantation after assisted reproduction. Fertil. Steril. 62:1004–1010. Edelman, J. L., Castro, M. R., and Wen, Y. 1999. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest. Ophthalmol. Vis. Sci. 40:1112–1123. Enders, A. C. 1989. Trophoblast differentiation during the transition from trophoblastic plate to lacunar stage of implantation in the rhesus monkey and human. Am. J. Anat. 186:85–98. Enders, A. C., and King, B. F. 1991. Early stages of trophoblastic invasion of the maternal vascular system during implantation in the macaque and baboon. Am. J. Anat. 192:329–346. Ferenczy, A. 1987. Anatomy and histology of the uterine corpus. In: Durman, T. G., ed. Blaustein’s Pathology of the Genital Tract, 3rd ed. Springer, New York, pp. 257–291. Ferenczy, A., Bertrand, G., and Gelfand, M. M. 1979. Proliferation kinetics of human endometrium during the normal menstrual cycle. Am. J. Obstet. Gynecol. 133:859–867 Ferriani, R. A., Charnock-Jones, D. S., Prentice, A., Thomas, E. J., and Smith, S. K. 1993. Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum. Reprod. 8:11–16. Fraser, I. S., and Peek, M. J. 1992. Effects of exogenous hormones on endometrial capillaries. In: Alexander N. J., and d’Arcangues, C., eds. Steroid Hormones and Uterine Bleeding. AAAS Press, Washington, pp. 67–79. Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C., Soker, S., Niknejad, K., Peoples, G. E., and Klagsbrun, M. 1995. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res. 55:4140–4145. Freitas, S., Meduri, G., Le Nestour, E., Bausero, P., and Perrot-Applanat, M. 1999. Expression of metalloproteinases and their inhibitors in blood vessels in human endometrium. Biol. Reprod. 61:1070–1082. Fujimoto, J., Hori, M., Ichigo, S., and Tamaya, T. 1996. Expression of basic fibroblast growth factor and its mRNA in uterine endometrium during the menstrual cycle. GynecoL Endocrinol. 10:193–197. Gannon, B. J., Carati, C. J., and Verco, C. J. 1997. Endometrial perfusion across the normal human menstrual cycle assessed by laser Doppler fluxmetry. Hum. Reprod. 12:132–139. Gargett, C. E., Lederman, F. L., Lau, T. M., and Rogers, P. A. W. 1999. Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium. Hum. Reprod. 14:2080–2088. Garlanda, C., and Dejana, E. 1997. Heterogeneity of endothelial cells. Specific markers. Arterioscler. Thromb. Vasc. BioL 17:1193–1202. Gaudry, M., Bregerie, O., Andrieu, V., El Benna, J., Pocidalo, M. A., and Hakim, J. 1997. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 90:4153–4161. Giudice, L. C. 1994. Growth factors and growth modulators in human uterine endometrium: their potential relevance to reproductive medicine. Fertil. Steril. 61:1–17. Goodger, A. M., and Rogers, P. A. W. 1994. Endometrial endothelial cell proliferation during the menstrual cycle. Hum. Reprod. 9:399–405. Goodger, A. M., and Rogers, P. A. W. 1995. Blood vessel growth in the endometrium. Microcirculation 2:329–343. Graham, J. D., and Clarke, C. L. 1997. Physiological action of progesterone in target tissue. Endocr. Rev. 18:502–519. Graubert, M. D., Mortola, J. F., Kessel, B., and Iruela-Arispe, M. L. 1997. Upregulation of vascular endothelial growth factor in the menstrual phase of normal endometrium may be mediated by hypoxia. Presented at the Society of Gynecology Investigation, San Diego, March 1997. Hanahan, D. 1997. Signalling vascular morphogenesis and maintenance. Science 277:48–50. Harmey, J. H., Dimitriadis, E., Kay, E., Redmond, H. P., and Bouchierhayes, D. 1998. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor (3–1. Ann. Surg. Oncol. 5:271–278. Hertig, A. T., Rock, J., and Adams, E. C. 1956. A description of 34 human ova within the first 17 days of development. Am. J. Anat. 98:435–493. Hii, L., and Rogers, P. A. W. 1998. Endometrial vascular and glandular expression of inte-grin ŒV 33 in women with and without endometriosis. Hum. Reprod. 13:1030–1035. Hornung, D., Lebovic, D. I., and Shifren, J. L. 1998. Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil. Steril. 69:909–915. Iruela-Arispe, M. L., Porter, P., Bornstein, P., and Sage, E. H. 1996. Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J. Clin. Invest. 197:403–412. Iruela-Arispe, M. L., Rodriguez-Manzaneque, J. C., and Abu-Jawdeh, G. 1999. Endome-trial endothelial cells express estrogen and progesterone receptors and exhibit a tissue specific response to angiogenic growth factors. Microcirculation 6:127–140. Kamphaus, G. D., Colorado, P. C., Pandi, D. J., Hopfer, H., Ramchandran, R., and Torre, A. 2000. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J. BioL Chem. 275:1209–1215. Keightley, M.-C. 1998. Steroid receptor isoforms: exception or rule? Mol. Cell. Endocrinol. 137:1–5. Kelly, F. D., Tawia, S. A., and Rogers, P. A. W. 1995. Immunohistochemical characterisation of human endometrial microvascular basement membrane components during the normal menstrual cycle. Hum. Reprod. 10:268–276. Koh, S. C. L., Wong, P. C., Yuen, R., Chua, S. E., Ng, B. L., and Ratnam, S. S. 1992. Concentration of plasminogen activators and inhibitor in the human endometrium at different phases of the menstrual cycle. J. Reprod. Fertil. 96:407–413. Kuiper, G. G., and Gustafsson, J. A. 1997. The novel estrogen receptor-13 subtype: potential role in the cell-and promoter-specific actions of estrogens and anti-estrogens. FEBS Lett. 410:87–90. Lau, T. M., Affandi, B., and Rogers, P. A. 1999. The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. Mol. Hum. Reprod. 5:57–63. Li, F. X., Gregory, J., and Ahmed, A. 1994. Immunolocalisation of vascular endothelial growth factor in human endometrium. Growth Factors 11:277–282. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., Daly, T. J., Davis, S., Sato, T. N., and Yancopoulos, G. D. 1997. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60. Markee, J. E. 1940. Menstruation in intraocular endometrial transplants in the rhesus monkey. Contrib. Embryo. Carnegie Inst. 28:219–308. McCarthy, S. A., Kuzu, I., and Gatter, K. C. 1991. Heterogeneity of the endothelial cell and its role in organ preference of tumour metastasis. Trends Pharmacol. Sci. 12:462–467. Meduri, G., Bausero, P., and Perrot-Applant, M. 2000. Expression of vascular endothelial growth factor receptors in the human endometrium: modulation during the menstrual cycle. Biol. Reprod. 62:439–447. Narukawa, S., Kanzaki, H., Inoue, T., Imai, K., Higuchi, T., and Hatayama, H. 1994. Androgens induce prolactin production by human endometrial stromal cells in vitro. J. Clin. Endocrinol. Metab. 78:165–168. Nasr, A., and Breckwoldt, M. 1998. Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg. Gynecol. Endocrinol. 12:43–59 Noyes, R. W., Hertig, A. T., and Rock, J. 1950. Dating the endometrial biopsy. Fertil. Steril1:3–25. O’Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., and Lane, S., Flynn E., Birkhead, J. R., Olsen, B. R., and Folkman, J. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277–285. O’Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the supression of metastases by a Lewis lung carcinoma. Cell 79:315–328. O’Reilly, M. S., Pirie-Shepherd, S., Lane, W. S., and Folkman, J. 1999. Antiangiogenic acitivity of cleaved conformation of the serpin antithrombin. Science. 285:1926–1928. Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J. A., Kushner, P. J., and Scanlon, T. S. 1997. Differential ligand activation of estrogen receptors ERa and ER(3 at API sites. Science 277:1508–1510. Ramos, M. A., Kuzuya, M., Esaki, T., Miura, S., Satake, S., Asai, T., Kanda, S., Hayashi, T., and Iguchi, A. 1998. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions. Arterioscler.Thromb.Vasc. Biol. 18:1188–1196. Ramsey, E. M. 1989. Vascular anatomy. In: Wynn, R. M., and Jollie, W. P., eds. Biology of the Uterus, 2nd ed. Plenum Publishing, New York, pp. 57–68. Roberts, D. K., Parmley, M. C., Walker, N. J., and Horbelt, D. V. 1992. Ultrastructure of the microvasculature in the human endometrium throughout the normal menstrual cycle. Am. J. Obstet. Gynecol. 166:1393–1406. Rogers, P. A. W., Au, C. L., and Affandi, B. 1993. Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum. Reprod. 8:1396–1404. Rogers, P. A. W., and Gargett, C. E. 1999. Endometrial angiogenesis. Angiogenesis 2:287–294. Rogers, P. A. W., Lederman, F., Kooy, J., Taylor, N. H., and Healy, D. L. 1996. Endometrial vascular smooth muscle oestrogen and progesterone receptor distribution in women with and without menorrhagia. Hum. Reprod. 11:2003–2008. Rogers, P. A. W., Lederman, F., and Taylor, N. 1998. Endometrial microvascular growth in normal and dysfunctional states. Hum. Reprod. Update 4:503–508. Salamonsen, L. A. 1996. Matrix metalloproteinases and their tissue inhibitors in endometrial remodelling and menstruation. Reprod. Med. Rev. 5:185–203. Sanghah, R. K., Li, X. F., Shams, M., and Ahmed, A. 1997. Fibroblast growth factor receptor-1 is a critical component for endometrial remodeling: localization and expres-222 P.A.W. Rogers and C.E. Gargettsion of basic fibroblast growth factor and FGF-R1 in human endometrium during the menstrual cycle and decreased FGF-R1 expression in menorrhagia. Lab. Invest. 77:389–402. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., GendronMaguire, M., Gridley, T., Wolburg, H., Risau, W., and Qin, Y. 1995. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70–74. Shifren, J. L., Tseng, J. F., Zaloudek, C. J., Ryan, I. P., Meng, Y. G., Ferrara, N., Jaffe, R. B., and Taylor, R. N. 1996. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J. Clin. Endocrinol. Metab. 81:3112–3118. Smith, S. K. 1995. Angiogenic growth factor expression in the uterus. Hum. Reprod. Update 1:162–173. Steer, C. V., Tan, S. L., and Dillon, D. 1995. Vaginal color Doppler assessment of uterine artery impedance correlates with immunohistochemical markers of endometrial receptivity required for the implantation of an embryo. Fertil. Steril. 63:101–108. Sunderkötter, C., Steinbrink, K., Goebeler, M., Bhardwaj, R., and Sorg, C. 1994. Macrophages and angiogenesis. J. Leukoc. Biol. 55:410–422. Taichman, N. S., Young, S., Cruchley, A. T., Taylor, P., and Paleolog, E. 1997. Human neutrophils secrete vascular endothelial growth factor. J. Leukoc. Biol. 62:397–400. Tawia, S. A., Beaton, L. A., and Rogers, P. A. W. 1993. Immunolocalization of the cellular adhesion molecules, intercellular adhesion molecule-1 (ICAM-1) and platelet endothelial cell adhesion molecule (PECAM), in human endometrium throughout the menstrual cycle. Hum. Reprod. 8:175–181. Torry, D. S., and Torry, R. J. 1997. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am. J. Reprod. Immunol. 37:21–29. Wang, J.-D., Fu, Y., Shi, W.-L., Zhu, P. D., Cheng, J., Qiao, G. M., Wang, Y. Q., and Greene, G. L. 1992. Immunohistochemical localisation of progesterone receptor in human decidua of early pregnancy. Hum. Reprod. 7:123–127. Webb, N. J., Myers, C. R., Watson, C. J., Bottomley, M. J., and Brenchley, P. E. 1998. Activated human neutrophils express vascular endothelial growth factor (VEGF). Cytokine 10:254–257. Editor information Editors and Affiliations Rights and permissions Copyright information © 2001 Springer Science+Business Media New York About this chapter Cite this chapter Rogers, P.A.W., Gargett, C.E. (2001). The Vascular System in the Endometrium: Introduction and Overview. In: Augustin, H.G., Rogers, P.A.W., Iruela-Arispe, M.L., Smith, S.K. (eds) Vascular Morphogenesis in the Female Reproductive System. Cardiovascular Molecular Morphogenesis. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4612-0213-4_11 Download citation DOI: https://doi.org/10.1007/978-1-4612-0213-4_11 Publisher Name: Birkhäuser, Boston, MA Print ISBN: 978-1-4612-6665-5 Online ISBN: 978-1-4612-0213-4 eBook Packages: Springer Book Archive

Keywords

- Vascular Endothelial Growth Factor - Progesterone Receptor - Menstrual Cycle - Secretory Phase - Endothelial Cell Proliferation These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (80)

Cited by (2)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
unpaywall
last seen: 2026-08-02T06:40:33.490260+00:00
License: CC0 · commercial use OK